Bristol Myers Squibb (CELG-RI) EPS (Basic) (2009 - 2026)
Bristol Myers Squibb (CELG-RI) posted quarterly EPS (Basic) of $1.62 for Q2 2026, up 151.69% year-over-year from $0.65 in Q2 2025, and up 23.54% quarter-over-quarter from $1.31 in Q1 2026.
Bristol Myers Squibb (CELG-RI) EPS (Basic) (2009 - 2026) Analysis & Trends
Bristol Myers Squibb (CELG-RI) has reported EPS (Basic) for 18 consecutive years, with $1.62 the latest figure, recorded in Q2 2026.
- In Q2 2026, EPS (Basic) rose 151.69% year-over-year to $1.62; the TTM figure through Jun 2026 stood at $4.54 (up 82.48% YoY), while the FY2025 annual figure was $3.47, up 178.72% from the prior year.
- EPS (Basic) advanced to $1.62 in Q2 2026 per CELG-RI's latest filing, from $1.31 in the prior quarter.
- Across five years, EPS (Basic) topped out at $1.62 in Q2 2026 and bottomed at -$5.89 in Q1 2024.
- Historically, EPS (Basic) has averaged $0.49 across 5 years, with a median of $0.84 in 2024.
- Annual changes were most pronounced in 2024 — EPS (Basic) slumped 645.01% — and 2025, when it jumped 1324.03%.
- Bristol Myers Squibb's EPS (Basic) stood at $0.95 in 2022, then dropped by 10.42% to $0.85 in 2023, then sank by 95.6% to $0.04 in 2024, then soared by 1324.03% to $0.53 in 2025, then soared by 204.14% to $1.62 in 2026.
- Business Quant data shows CELG-RI's EPS (Basic) at $1.62 in Q2 2026, $1.31 in Q1 2026, and $0.53 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.37 Bn | 632.61 Bn | 17.26 Bn | 2.30 |
| 2 | AbbVie | 470.31 Bn | 463.74 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 377.07 Bn | 369.93 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 303.14 Bn | 295.45 Bn | 11.24 Bn | 1.71 |
| 5 | Astrazeneca | 257.68 Bn | 252.78 Bn | 12.86 Bn | 1.62 |
| 6 | Amgen | 236.33 Bn | 222.34 Bn | 7.24 Bn | 4.40 |
| 7 | Gilead Sciences | 182.14 Bn | 178.96 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 159.30 Bn | 147.60 Bn | 10.94 Bn | -0.04 |
| 9 | Gsk | 106.20 Bn | 102.03 Bn | 8.24 Bn | 0.29 |
| 10 | Bristol Myers Squibb | 224.21 Mn | -10.84 Bn | 9.25 Bn | 1.62 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.62 |
| Mar 31, 2026 | 1.31 |
| Dec 31, 2025 | 0.53 |
| Sep 30, 2025 | 1.08 |
| Jun 30, 2025 | 0.65 |
| Mar 31, 2025 | 1.21 |
| Dec 31, 2024 | 0.04 |
| Sep 30, 2024 | 0.60 |
| Jun 30, 2024 | 0.83 |
| Mar 31, 2024 | -5.89 |
| Dec 31, 2023 | 0.85 |
| Sep 30, 2023 | 0.94 |
| Jun 30, 2023 | 0.99 |
| Mar 31, 2023 | 1.08 |
| Dec 31, 2022 | 0.95 |
| Sep 30, 2022 | 0.75 |
| Jun 30, 2022 | 0.67 |
| Mar 31, 2022 | 0.60 |
| Dec 31, 2021 | 1.07 |
| Sep 30, 2021 | 0.70 |